Lisbon Addictions 2015: First European conference on addictive behaviours and dependencies
The First European conference on addictive behaviours and dependencies is being held in Lisbon on 23–25 September 2015. It is organised by the Portuguese General-Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD — Serviço de Intervenção nos Comportamentos Aditivos e nas Dependências) the journal Addiction, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the International Society of Addiction Journal Editors (ISAJE).
It's a comprehensive and multi-disciplinary event, showcasing leading European addiction research in the specialist areas of illicit drugs, alcohol, tobacco, gambling and other addictive behaviours. It addresses new challenges and covers developing fields such as new psychoactive substances, online sales and gambling, cannabis legalisation and alcohol pricing.
About the conference
- More information on the EMCDDA's presence at the conference can be found below.
- The conference takes place at the FIL Expo conference centre in the beautiful city of Lisbon.
- It will showcase European addiction science covering illicit drugs, alcohol, tobacco, gambling and other addictive behaviours.
- It will cover epidemiology, policy research, clinical research, social sciences, behavioural science and human psychopharmacology.
- There will be invited keynote presentations from European and international top addiction experts, opportunities to present new findings, multi-disciplinary workshops and discussion forums.
- A call for abstracts will be published in the autumn.
- The conference is also intended as a major networking event and facilities will be available to support network and specialist meetings in its margins.
Participation from candidate countries and potential candidates and neighbourhood countries
Participation of experts from Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Kosovo*, and Serbia was financed by IPA 5 project funds.
Within the framework of ENPI technical cooperation project ‘Towards a gradual improvement of ENP partner countries’ capacity to monitor and to meet drug-related challenges’ funded by the European Commission, participation of drug-monitoring experts from Georgia, Morocco, Moldova and Israel, respectively, was supported.
Wednesday 23 September
| Time | Location | Type | Who | What |
|---|---|---|---|---|
| all day | ground floor, entrance | EMCDDA | EMCDDA exhibition stand | |
| 10:00-10:30 | Opening ceremony | Wolfgang Götz, EMCDDA | Opening speech | |
| 12:45-14:15 | Room 1 | Sponsored session 1 | EMCDDA | EMCDDA face to face: learn more about the EU drugs agency and its work. |
| 12:45-14:15 | Room 3 | Sponsored session 3 | Alexis Goosdeel, EMCDDA/NIDA | 1995-2015: 20 years of experience in building national drug observatories |
| 14:30-16:00 | Auditorium I | Symposium session A: Cannabis addiction: what is the problem? | Paul Griffiths, EMCDDA | PRESENTATION Cannabis addiction: does epidemiology vary with a country’s drug policy? |
| 16:30-18:00 | Room 2 | Paper session 5: Perspectives on addictions: criminal justice | Liesbeth Vandam, EMCDDA | CHAIR |
| 16:30-18:00 | Room 2 | Paper session 5:Perspectives on addictions: criminal justice | Brendan Hughes, EMCDDA | PRESENTATION Perspectives on addictions: criminal justice |
| 16:30-18:00 | Rapid communication | Alessandro Pirona, EMCDDA | POSTER The neglected impact of nicotine addiction in understanding cannabis dependence among European cannabis smokers | |
| 16:30-18:00 | Rapid communication | Cláudia Costa Storti, EMCDDA | POSTER Financing health and drug policy in Europe in the wake of the 2008-2009 recession: an economic analysis | |
| 18:30 | Opening reception | 2015 EMCDDA SCIENTIFIC PAPER AWARD CEREMONY |
Thursday 24 September
| Time | Location | Type | Who | What |
|---|---|---|---|---|
| all day | ground floor, entrance | EMCDDA exhibition stand | ||
| 11:00-12:30 | Auditorium II | Paper session 12: Treating addictions: new insights for therapy | Dagmar Hedrich, EMCDDA | CHAIR |
| 11:00-12:30 | Room 3 | Paper session 10: New opportunities for harm reduction: behaviours | Ana Gallegos, EMCDDA | PRESENTATION Recent developments in the detection of harms arising from the use of synthetic cathinones in Europe. |
| 11:00-12:30 | Auditorium I | Paper session 14: Prevention: theory and evidence | Marica Ferri, EMCDDA | PRESENTATION Knowledge exchange and evidence-base for decision-making: can promptness and accuracy go together? |
| 11:00-12:30 | Room 5 | Symposium session F: Drug users in prison: interventions to reduce harm and enable recovery | Linda Montanari, EMCDDA | PRESENTATION Substance use and specific health needs of drug users inside European prisons: what do we know? |
| 11:00-12:30 | Rapid communication | Eoghan Quigley, EMCDDA | POSTER City level drug policies in Europe — a documentary analysis | |
| 11:00-12:30 | Rapid communication | Alessandro Pirona, EMCDDA | POSTER Ageing and addiction: are European addiction treatment systems ready for the challenges ahead? | |
| 12:45-14:15 | Room 3 | Sponsored session 9 | Reitox | Understanding the risks and benefits of OST in Europe: triangulating data from monitoring and research sources |
| 12:45-14:15 | Room 2 | Sponsored session 10 | EMCDDA/ECDC | Scaling up responses to hepatitis C among PWID in Europe: what are the priorities? A European agency and clinician’s perspective. |
| 14:30-16:00 | Auditorium I | Symposium session H: The European Drug Emergencies Network (Euro-DEN): insights into acute drug emergencies in Europe | Isabelle Giraudon, EMCDDA | CHAIR |
| 14:30-16:00 | Rapid communication | Charlotte Davies, UK (second author Maria Moreira) | Identifying research priorities for illicit drugs in Europe |
Friday 25 September
| Time | Location | Type | Who | What |
|---|---|---|---|---|
| all day | EMCDDA | EMCDDA exhibition stand | ||
| 11:00-12:30 | Room 5 | Symposium session L: | Alessandro Pirona, EMCDDA | CHAIR |
| 11:00-12:30 | Auditorium II | Paper session 22: Challenges: new developments in New Psychoactive Substances | Roumen Sedefov, EMCDDA | PRESENTATION New Psychoactive Substances in Europe — diversity and harms |
| 11:00-12:30 | Auditorium III | Paper session 25: Challenges: a changing drug market | Jane Mounteney, EMCDDA | PRESENTATION A game changer? Results from the EMCDDA study on the Internet and drug markets. |
| 11:00-12:30 | Room 1 | Symposium session K: Addressing vulnerabilities, increasing access to services: how to mainstream gender into policy and practice of substance use prevention treatment and rehabilitation | Marica Ferri, EMCDDA | PRESENTATION Addressing gender inequalities in accessing drug addiction services in Europe: challenges and good practices |
| 11:00-12:00 | Rapid communication | Roumen Sedefov, EMCDDA | POSTER New Psychoactive Substances in Europe | |
| 11:00-12:00 | Rapid communication | Andrew Cunningham, EMCDDA | POSTER Recent developments in detection of harms arising from the use of synthetic cannabinoid receptor agonists in Europe. | |
| 11:00-12:00 | Rapid communication | João Matias, EMCDDA | POSTER Cannabis-related indicators: up or down? Good or bad? What do the data tell us? | |
| 11:00-12:00 | Rapid communication | Nicola Singleton, EMCDDA | POSTER Old dog, new tricks? Making use of opiate supply and markets information for horizon scanning. | |
| 11:00-12:00 | Rapid communication | Danilo Ballotta, EMCDDA | POSTER Regional drug strategies across the world | |
| 11:00-12:00 | Rapid communication | Charlotte Colman, Belgium (second author Danilo Ballotta, EMCDDA) | European guidelines for the evaluation of national drug strategies and action plans. | |
| 12:30-13:00 | Closing session | Paul Griffiths, EMCDDA | Speech |
Main subject